Improved outcome of Pediatric-inspired protocol for high risk adolescent and young adult (AYA) acute lymphoblastic leukemia utilizing peg-asparaginase and escalating dose of methotrexate, tolerability and outcome
ConclusionThe use of pediatric-inspired protocol for high risk AYA ALL was effective and well tolerated with improvement in OS and DFS compared to historical data using adult protocols in such population
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Cancer | Cancer & Oncology | Cancer in Adolescents | Cancer in Young Adults | Chemotherapy | History of Medicine | Leukemia | Lymphoma | Methotrexate | Myeloma | Pediatrics | Study | Toxicology